MedPath

Transcutaneous Electrical Nerve Stimulation for Labor Pain Control

Not Applicable
Completed
Conditions
Labor Pain
Interventions
Device: DS5 electrical stimulator
Registration Number
NCT04894539
Lead Sponsor
Aalborg University
Brief Summary

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive electro-physical modality used for several pain conditions including labor pain control. Despite several years of research, there is still no agreement within the literature regarding the selection of TENS parameters. It is aimed to investigate two types of TENS frequencies (TENS1 alternating between 4 to 100 Hz and TENS2 alternating between 80 to 100 Hz) compared to sham-TENS.

Detailed Description

Midwives and the study investigator will ask parturients, who are admitted to the labor ward at Region Hospital Herning satisfying the inclusion and exclusion criteria, whether they are interested in attending the experimental session.

The study will be conducted as soon as the subject is admitted at the labor ward. The study will only be conducted during early and active labor and not during the birth of the baby.

The subject in this study includes the package of a parturient and her neonate (after birth) as we also obtain data about the neonate. Hereby, two consent forms will be obtained. As this study is a non-invasive study, it is decided to have at least the consent of one parent.

The investigator will fill out a questionnaire about the parturient in cooperation with the subject and midwife, including screening questions related to inclusion and exclusion criteria before the experimental session starts.

The study will last approximately one hour and will be conducted during laboring circumstances. KT (Kenoja Thuvarakan) will carry out the experiment, and she will be present in the delivery room during the whole session.

The study includes several outcomes, including subjective and semi-objective pain measures. The primary outcome is VAS (0-10 cm scale), while secondary outcomes include PPT and satisfaction questionnaire (only at the end of the study). The subjects will be asked before, and immediately after the experimental exposure about the four outcomes (VAS and PPT). The subjects will be exposed to one of the two combinations of TENS stimulation (low and high alternating frequency), which will be compared to sham-TENS.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
12
Inclusion Criteria
  • Singleton pregnancy
  • Between ages 18-39 years
  • Vertex presentation
  • Speak, read and understand Danish
  • At term (37-42 weeks gestation age)
Exclusion Criteria
  • High-risk pregnancies (including risk factors: eclampsia, pre-eclampsia, diabetes, gestational diabetes, hypertension, and hypotension, intrauterine growth restriction, polyhydramnios, and oligohydramnios).
  • Pre-gestational body mass index above 40 kg/m2
  • Use of fetal-scalp electrode during the experiment
  • Use of pacemakers and other electronic implants
  • Severe arrhythmia
  • Present musculoskeletal/neurological illnesses
  • Chronic pain within last 6 months
  • Present medicated mental disorders
  • Dermatological disorders
  • Use of other long-acting pain relief
  • Use of TENS 48 hours before the trial
  • Drug addiction defines as the use of cannabis, opioids, or other drugs.
  • Smokers
  • Lack of ability to cooperate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham-TENSDS5 electrical stimulatorSham with 100 Hz in frequency, 200 µs in pulse duration, and intensity below 5 mA.
TENS1DS5 electrical stimulatorTENS with 4/100 Hz in frequency, 200 µs in pulse duration, and intensity individually adjusted.
TENS2DS5 electrical stimulatorTENS with 80/100 Hz in frequency, 200 µs in pulse duration, and intensity individually adjusted.
Primary Outcome Measures
NameTimeMethod
Change in Visual Analog scale (VAS)Baseline, 10 minutes post stimulation, 30 minutes post stimulation

10-cm pain intensity scale with 0 cm is no pain and 10 cm is unbearable pain. Decreased cm after baseline measurement indicates pain relief.

Change in Pain pressure thresholdBaseline, 10 minutes post stimulation, 30 minutes post stimulation

Pain sensitivity measurement also defined as the minimum pressure needed to evoke a pain response measured in kPa. Increased kPa after baseline measurement indicates pain relief.

Secondary Outcome Measures
NameTimeMethod
Recommend TENS to othersRight after last measurements of VAS & PPT

Response to yes, no, or don't know

Satisfaction of TENSRight after last measurements of VAS & PPT

Satisfaction rating on scale from 0 to 10 \[0 as 'no satisfaction' and 10 as 'total satisfaction'\].

Experienced pain reductionRight after last measurements of VAS & PPT

Response to yes or no

Interest in the use of TENS againRight after last measurements of VAS & PPT

Response to yes, no, or don't know

Trial Locations

Locations (1)

Region Hospital Gødstrup

🇩🇰

Herning, Denmark

Region Hospital Gødstrup
🇩🇰Herning, Denmark
© Copyright 2025. All Rights Reserved by MedPath